Every December, retirees sell shares they would rather keep just to satisfy an IRS deadline they never asked for. A three-holding portfolio built around yield might change that math entirely, but only up to a certain age.
Kenvue's operating margin has rebounded from 3.9% in Q2 2024 to 18.2% in Q3 2026, with net margin recovering to 11.1% and gross margin steady in a 56.5% to 59.5% band, suggesting improved pricing power in consumer health.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue has stabilized with modest year-over-year growth of 3.2% in Q3 2026 following earlier declines, while operating margin expanded to 18.2% and net margin to 11.1%, though the 21.9% Q1 2026 peak suggests the gains may be partly transitional.
KVUE's trailing and forward P/E ratios of 24.93 and 17.01 respectively indicate attractive valuation potential.
Multiple bullish theses on Kenvue Inc. have been published by analysts like Danny Green and ZeeContrarian1, highlighting positive sentiment.
A bullish thesis was published before KVUE's acquisition, suggesting underlying strength and growth prospects.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 30, 2026 | $0.29-0.5% vs $0.29 | $3.9B+0.6% vs $3.9B |
Q3 2026 Aug 6, 2026 | $0.31-2.7% vs $0.32 | $4.0B-0.3% vs $4.0B |
Q2 2026 May 7, 2026 | $0.32+22.1% vs $0.26 | $3.9B+1.7% vs $3.8B |
Q1 2026 Feb 17, 2026 | $0.27+21.2% vs $0.22 | $3.8B+2.6% vs $3.7B |
Every December, retirees sell shares they would rather keep just to satisfy an IRS deadline they never asked for. A three-holding portfolio built around yield might change that math entirely, but only up to a certain age.
KMB's Kenvue acquisition expands its global health and wellness footprint, strengthening its brand portfolio and creating new avenues for long-term growth.
DALLAS, Nov. 3, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today the final results of the offers to exchange (each an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes (the "Kenvue Notes") issued by Kenvue LLC (as successor in interest to Kenvue Inc.) ("Kenvue") for up to $7,000,000,000 aggregate principal amount of new notes to be issued by Kimberly-Clark (the "Kimberly-Clark Notes") and cash and related consent solicitations (each, a "Consent Solicitation" and, collectively, the "Consent Solicitations") made by Kimberly-Clark on behalf of Kenvue to adopt certain amendments (the "Amendments") to the indenture governing the Kenvue Notes (the "Kenvue Indenture"). The Exchange Offers and Consent Solicitations expired at 5:00 p.m.
That's expensive, but the tie-up is complementary in several ways. The buyer is also likely to find a way of keeping its Dividend King status alive.
Benchmark KVUE against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Kenvue Inc. (KVUE)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $19.31 | $37.08B | 22.01 | -2.14% | 10.88% | 16.06% | 4.26% | |
| $165.40 | $385.15B | 24.84 | 3.26% | 18.23% | 29.42% | 2.55% | |
| $96.56 | $77.27B | 37.58 | 1.4% | 9.65% | 399.22% | 2.33% | |
| $109.33 | $25.91B | 33.68 | 1.57% | 12.41% | 18.21% | 1.08% | |
| $110.06 | $39.81B | 109.49 | 5.05% | 2.41% | 9.28% | 1.27% | |
| $15.85 | $2.19B | -1.25 | -2.75% | -43.27% | -68.13% | 7.26% |
Kenvue Inc. (KVUE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Kenvue Inc. (KVUE) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 30, 2026·SEC
Oct 13, 2026·SEC
Aug 6, 2026·SEC
Feb 20, 2026·SEC
Get notified when KVUE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Kenvue Inc. (KVUE) stock FAQ — growth, dividends, profitability & financials explained
Kenvue Inc. (KVUE) reported $15.53B in revenue over the trailing twelve months. Revenue was $15.12B in fiscal year 2025. That is 5% more than the $14.47B of fiscal year 2020.
Kenvue Inc. (KVUE) grew revenue by 3.5% over the trailing twelve months, compared with the twelve months before.
Yes. Kenvue Inc. (KVUE) earned $1.69B in net income over the trailing twelve months (a 10.9% net margin).
Yes. Kenvue Inc. (KVUE) pays a dividend that yields 4.26% at the current price, a high yield.
Kenvue Inc. (KVUE) had a return on equity (ROE) of 16.1% over the trailing twelve months. That is above the market's typical 10-15%.
Kenvue Inc. (KVUE) generated $2.54B in free cash flow over the trailing twelve months.